| abstract |
The present invention relates to inhibitors of myeloid leukemia protein 1 (Mcl-1), methods for their preparation, pharmaceutical compositions thereof, and methods of use thereof. The invention relates, for example, to compounds of formula I, or a stereoisomer thereof; and pharmaceutically acceptable salts of these compounds, as well as pharmaceutical compositions containing said compounds. The compounds and compositions according to the invention can be used, for example, in the treatment of diseases or pathological conditions such as cancer. |